Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

36 recalls, newest first

Class I · High risk

X-ROCK 3 Day Pill For Men

Marketed Without an Approved NDA/ANDA: Products tested positive for Sildenafil and analogs of Sildenafil.

Terminated Chemical / undeclared Coral Rock Man, Inc. D-038-2013
Class III · Low risk

Erythromycin Topical Solution USP

Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.

Terminated Chemical / undeclared Fougera Pharmaceuticals, Inc. NDC 0168-0215-60 D-1426-2012
Class I · High risk

V Maxx Rx

Marketed Without An Approved NDA/ANDA: Samples tested by FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction, making these products unapproved new drugs.

Terminated Chemical / undeclared The Menz Club, LLC D-1657-2012
Class I · High risk

a) Firminite 805 mg is packaged in 2 count

Marketed Without an Approved NDA/ANDA: These products found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making these products unapproved new drugs.

Terminated Chemical / undeclared InSo-Independent Contractor for West Coast Nutritionals,LTD D-326-2013
Class I · High risk

X-ROCK For Men

Marketed Without an Approved NDA/ANDA: product tested positive for PDE-5 Sildenafil and PDE-5 Hydroxythiohomosildenafil. Hydroxythiohomosildenafil is an analog of sildenafil, an FDA approved prescription drug for Erectile Dysfunction (ED).

Terminated Chemical / undeclared XRock Industries, LLC D-037-2013
Class I · High risk

Blue Male Enhancement Pill

Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug

Ongoing Chemical / undeclared The Menz Club, LLC D-266-2013
Class II · Moderate risk

Lipitor (Atorvastatin calcium)

Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.

Terminated Chemical / undeclared Physicians Total Care, Inc. NDC 54868-4229-0 D-1389-2012

Recalls by year